FAA Proposes AME-Issued Medicals

The Federal Aviation Administration has proposed a change to its medical certification rules that would let pilots whose diabetes is managed without insulin receive first-, second- or third-class medical certificates directly from an aviation medical examiner. The notice is scheduled for Federal Register publication on 4 September, with a 30-day comment window.

What changes

Under current rules, diabetes requiring insulin or another hypoglycaemic drug for control is a specifically disqualifying condition. Pilots using non-insulin medication can hold a medical certificate, but an AME generally must defer the application to the FAA for Special Issuance review — a process that can stretch application timelines by months and, for first-class applicants on airline career timelines, sits awkwardly against type rating courses and hiring windows.

The proposal removes non-insulin medications from that disqualifying provision. Qualified applicants would be evaluated under the FAA's general medical standards, letting the AME issue the certificate at the time of examination — the same visit that currently ends in a deferral letter.

The numbers

The FAA estimates the change would let AMEs issue certificates at the time of examination in about 3,000 cases each year, with another 1,200 cases currently handled through Special Issuance potentially transitioning to AME-managed certification. Over five years, the agency puts applicant savings at US$39.7 million to US$80.2 million in labour costs.

The agency's stated rationale is clinical, not administrative: non-insulin diabetes treatment has advanced substantially since the original standard was written in 1959, improving disease management and reducing the safety risk the Special Issuance process was designed to manage. The FAA also expects the change to reduce its own processing workload — every case an AME issues directly is a file that never enters the federal queue.

Who is not covered

The line is drawn at insulin. Pilots whose diabetes requires insulin remain outside the proposal entirely — insulin-treated applicants continue to require Special Issuance authorisation, and the 1959-era disqualifying structure stays in place for them.

The proposal also preserves discretion at the point of issuance. Pilots using non-insulin treatments could still be denied or deferred on a case-by-case basis where the FAA or the AME judges the condition or treatment could interfere with the safe exercise of pilot privileges. An AME-issued certificate under the new pathway would still be a valid medical, subject to the same class privileges and duration rules as any other.

Why it matters for the training pipeline

For flight schools and charter operators, the practical effect is a wider pool of candidates who can hold the medical certificate required for a CPL or an air transport career without a deferral in their file. Medical certification is one of the quiet attrition points in pilot training — students who discover a disqualifying-or-deferred condition mid-course sometimes leave training altogether, and the decision rarely waits for a federal review cycle to conclude. A faster, examiner-level pathway for the non-insulin diabetic population removes one version of that risk.

For existing pilots, the change removes an administrative cycle most encounter on every renewal: the deferred application, the additional documentation, and the wait. Under the proposal, a well-controlled non-insulin diabetic pilot would renew the way any other pilot does — in the AME's office, at the appointment. The distinction matters most for class 1 holders on airline schedules, where a deferral landing between type rating courses or line checks creates exactly the timing risk the Special Issuance process never accounted for.

The change also affects how schools counsel prospective students. Questions about medical eligibility are among the first asked at any open day, and the honest answer for non-insulin diabetic applicants shifts from "it depends on a federal review" to "your examiner can issue it at the appointment" — a materially different conversation for a 17-year-old weighing a training investment.

What to watch

The 30-day comment window closes in early October, and the final rule's shape will depend on what the docket receives — expect input from pilot advocacy groups, aeromedical organisations, and the operators whose hiring pipelines the change touches. Comments on the proposal run through the standard Federal Register docket, and the FAA's cost and caseload estimates are both open to challenge in that process. If the rule is adopted as proposed, implementation turns on AME guidance rather than new infrastructure: the examiners already exist, the forms already exist, and the examination pathway is the one they use every working day.

The proposal sits alongside broader FAA moves to modernise medical certification, including the BasicMed expansion and earlier telehealth and special-issuance streamlining work. For pilots affected by the current deferral process, the practical advice until the rule lands is unchanged: keep documentation of control and treatment current, because that file is what the AME reviews either way. Watch the docket for the final rule timing and any conditions the agency attaches at the AME-issuance level.